Suppr超能文献

[心脏瓣膜感染性心内膜炎的手术时机]

[Timing of surgery in heart valve infective endocarditis].

作者信息

Di Mauro Michele, Actis Dato Guglielmo, Sponga Sandro, Lorusso Roberto

机构信息

Cardio-Thoracic Surgery Unit, Heart and Vascular Centre, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands.

S.C. Cardiochirurgia, A.O. Mauriziano, Torino 3U.O.C. Cardiochirurgia, Azienda Ospedaliero-Universitaria S. Maria della Misericordia, Udine.

出版信息

G Ital Cardiol (Rome). 2020 Nov;21(11):890-895. doi: 10.1714/3455.34443.

Abstract

The prevalence of valvular infective endocarditis (IE) is increasing and is burdened by high mortality and morbidity. Despite the higher risk, the surgical approach is superior to medical therapy alone, and over the years there has been a more aggressive attitude, with earlier indications for surgery. This article aims to review the available literature and the American and European guidelines in order to summarize the most appropriate surgical timing for valvular IE. Although there are discrepancies between the guidelines, an emergent indication (<48 h) should be considered in patients with either native or prosthetic endocarditis with severe regurgitation, outflow obstruction, refractory acute pulmonary edema, cardiogenic shock, or large mobile vegetations (>15-20 mm). Patients with signs of heart failure, persistence of positive cultures for more than 48-72 h despite antibiotic therapy, and in the presence of paravalvular lesions, advanced atrioventricular block and vegetations >10 mm should be operated early (within a few days). If any micro-organisms are isolated, including fungi or multi-resistant organisms in native IE or staphylococci or gram-negative pathogens in prosthesis IE, a more watchful approach (within 2 weeks) should be evaluated. In the presence of large cerebral embolic strokes or cerebral hemorrhage, re-evaluation at 2 and 4 weeks, respectively, is more appropriate. A multidisciplinary approach, especially in the most complex cases, seems to improve the outcome.Key words. Heart valve dysfunction; Heart valve repair; Heart valve replacement; Heart valve surgery; Infective endocarditis; Timing of surgery.

摘要

心脏瓣膜感染性心内膜炎(IE)的患病率正在上升,且死亡率和发病率较高。尽管风险更高,但手术治疗优于单纯药物治疗,多年来人们的态度更为积极,手术指征也更早。本文旨在回顾现有文献以及美国和欧洲的指南,以总结心脏瓣膜IE最合适的手术时机。尽管指南之间存在差异,但对于患有严重反流、流出道梗阻、难治性急性肺水肿、心源性休克或大型活动赘生物(>15 - 20毫米)的天然瓣膜或人工瓣膜心内膜炎患者,应考虑紧急手术指征(<48小时)。有心力衰竭迹象、尽管接受抗生素治疗但血培养持续阳性超过48 - 72小时,以及存在瓣周病变、高级别房室传导阻滞和赘生物>10毫米的患者应尽早手术(在几天内)。如果分离出任何微生物,包括天然瓣膜IE中的真菌或多重耐药菌,或人工瓣膜IE中的葡萄球菌或革兰氏阴性病原体,则应评估采取更谨慎的方法(在2周内)。在发生大面积脑栓塞性中风或脑出血的情况下,分别在2周和4周进行重新评估更为合适。多学科方法,尤其是在最复杂的病例中,似乎能改善预后。关键词:心脏瓣膜功能障碍;心脏瓣膜修复;心脏瓣膜置换;心脏瓣膜手术;感染性心内膜炎;手术时机

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验